Ziprasidone
Pricing Report NDC 59762-2003-1

Latest NADAC: $0.28438 per EA · Effective Jul 17, 2024 · Est. package price $17.06 (60 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Ziprasidone (NDC 59762-2003-1) is $0.28438 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 17, 2024.

As a provided by Mylan Pharmaceuticals Inc., this medication is distributed in a 60 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.28438
Per EA

Effective Date
Jul 17, 2024
Billable Units
60 EA
Estimated Package Price
$17.06
Data Status
As of Aug 14, 2024
C/I - Chain or Independent Pharmacy
Package NDC
Description
60 CAPSULE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.27717 to $2.15180 per EA. Over this 10 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2772 - $2.1518
Market Volatility
676.35% Variance
Latest Trend
21.03%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 17, 2024 $0.28438 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2024 $0.36012 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2024 $0.29456 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2024 $0.27717 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 20, 2024 $0.36289 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 21, 2024 $0.40129 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 17, 2024 $0.37395 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 20, 2023 $0.37020 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 22, 2023 $0.36474 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 18, 2023 $0.34879 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 20, 2023 $0.32675 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 23, 2023 $0.35584 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026